Morning Snapshot
Market Pulse: Tech drifted the S&P into the red as investors digested mixed signals from major names and a surprise surge in oil costs.
Key Movers: Box stunned skeptics with a hefty earnings beat, WBD-Paramount got a regulatory green light, and Bitcoin hit a resistance wall just below $70K.
Macro & Politics: Fresh flare-ups in the Middle East reignited risk-off fervor, sending energy sectors higher and stalling talk of a near-term Fed rate cut.
What’s Next: Eyes on today’s earnings calendar and any Fed murmurs—volatile swings could spark tactical entries pre-bell.
Unfiltered Market Commentary
Everyone’s missing the real drag from oil’s rally. The “Middle East Tensions Send Oil Soaring, Stocks Tank” shockwave isn’t just about energy names—higher costs will squeeze margins across manufacturing and tech alike. That’s a hell of a catalyst that deserves more airtime than a fleeting tweetstorm.
Look at Box’s knock-out report in SiliconANGLE News alongside the brewing Bitcoin squeeze flagged by Ambcrypto.com: one story shows enterprises clinging to established cloud budgets, the other hints at a liquidity maelstrom when shorts cover. Together they spell a thesis that rock-solid fundamentals can outpace hype—if you know where the real risk lies.
Your play: lean into names with raised guidance and clear earnings momentum, but keep a fast trigger on any crypto breakouts. Scan for those setups now, because once FOMO hits, you’ll want to be in before the herd stamps over your position.
📈 Breaking Financial News
FCC chair calls Paramount/WBD merger “a lot cleaner” than defunct Netflix deal – Ars Technica
FCC chair calls Paramount/WBD merger “a lot cleaner” than defunct Netflix dealArs Technica FCC chief tells CNBC WBD-Paramount merger deal is ‘cleaner’ than Netflix's, will be approved ‘quickly'CNBC Paramount’s Debt Downgraded to Junk Following Warner Bros. Pu…
Bitcoin rejected at $70K again, but a short squeeze may still be brewing!
The 7-day moving average of the taker buy/sell ratio rose above 1 over the past week.
Box brushes aside fears of AI’s threat with powerful earnings beat
Box Inc. bucked the trend of software companies crumbling in the face of the artificial intelligence threat, crushing Wall Street’s profit forecast, beating expectations on earnings, and offering solid guidance going forward. The news sent Box’s stock up more…
Banijay and All3Media Near Merger Deal to Form Multi-Billion Dollar Production Group
Six years after buying out Endemol Shine in the thick of the pandemic, Banijay (“Big Brother,” “Peaky Blinders”) is about to close its merger deal with All3Media (“The Traitors”) to form an even bigger production powerhouse, Variety has confirmed. The joint e…
FCC chief tells CNBC WBD-Paramount merger deal is ‘cleaner’ than Netflix's, will be approved ‘quickly'
FCC Chairman Brendan Carr told CNBC on Tuesday that Netflix's previous Warner Bros. Discovery offer “raised a lot of competition concerns.”
How To Profit From Starlink's $180 Billion IPO Jackpot?
Have you heard the big news? Elon Musk's company Starlink is preparing to announce their IPO as soon as March 26th! According to Quartz, “Elon Musk's Starlink IPO may lift off any day now” And for the first time ever, you have the rare chance to see how to profit BEFORE the IPO takes place.
🔍 Market Analysis & Insights
MemoTril Cognitive Support Claims Evaluated: Latest 2026 Consumer Report Examines MemoTril Brain Supplement Ingredients, Memory Enhancement Marketing, and What Consumers Should Verify
Independent 2026 report examines MemoTril brain supplement cognitive support claims, ingredient research context, pricing, and what to verify….
AudiLeaf Ear Health Claims Evaluated: 2026 Report Examines Ingredients, Proprietary Blend Dosing, and What Consumers Should Verify Before Buying
Independent 2026 report examines AudiLeaf ear health claims, proprietary blend ingredients, pricing, refund terms, and what to verify first….
Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today provided an update on the potential spin-off of its biopharma operations and …
Pi Network price prediction: $0.20 still in play as 3 signals align
Over the past week, the 20DMA has served as a dynamic support to Pi Network token prices.
Circle shares boosted by Middle East tensions, rising oil, fading rate cut hopes, says Mizuho
The stock has risen about 20% since the U.S. strikes on Iran over the weekend.
The Liquidity Engine Powering Crypto's Comeback
Institutional capital is flooding in while most investors remain completely unaware – creating what could be the buying opportunity of a lifetime. Exposed: Crypto's liquidity backbone set for massive gains – get all details for just $3!
💰 Investment Opportunities
Pediatric trials aim to expand GLP-1 weight loss drugs to younger children
Pediatric trials are quietly underway to support prescribing GLP-1 medications for obesity in children under 12, despite concerns about their long-term effects on developing bodies. Originally designed to lower blood sugar for diabetics, injectables such as O…
How to get perfect skin: a no-BS lifter’s guide
I got a surprisingly large number of questions about skincare so I talked to a true expert.[Read More]
Stock market today: Dow plunges over 1,100 points, S&P 500 and Nasdaq sink as oil surges amid war worries
The fresh wave of Israeli-led attacks has jolted markets that on Monday mostly managed to shake off the initial shock of the outbreak.
Stock market today: Dow falls by 700 points, S&P 500 and Nasdaq sink as oil surges amid war worries
The fresh wave of Israeli-led attacks has jolted markets that on Monday mostly managed to shake off the initial shock of the outbreak.
Microbiome Market Competitive Landscape Report 2026: Comprehensive Insights About 140+ Companies and 180+ Drugs
The microbiome sector offers significant opportunities in personalized medicine targeting metabolic disorders, inflammatory bowel disease, and cancer. Innovations in immuno-oncology, oncology, and gastrointestinal conditions highlight potential for novel micr…
